Episode: A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk
Description: CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.Read this story here.
Learn about your ad choices: dovetail.prx.org/ad-choices
Click any word to see translations, usage examples & similar words. Then learn them using saved words.
Text not synced with the audio? See here for why certain podcasts won't sync.
